The authors aimed to evaluate the usefulness of various computed tomography (CT) findings including distribution of infiltration or fluid collection in differentiating the major etiologies of acute pancreatitis. Seventy-five severe cases of acute pancreatitis of alcoholic (n=43) or biliary stone (n=32) etiology having infiltration or fluid collection on CT were reviewed. The authors compared the pancreatic size, CT grading, presence or absence of biliary calculi, and dilatation of pancreatic or bile duct. They also evaluated degree and the distribution of infiltration and fluid collection in each group. The sizes of pancreas were not different between alcohol group and stone group. Alcohol group showed higher CT grading than stone group (P<0.05). Presence of biliary stone and duct dilatation was statistically significant in differentiating etiology (P<0.05). Alcohol group showed significantly prominent peripancreatic pathology than stone group only in left peritoneal compartment (P=0.020). In conclusion, alcoholic pancreatitis tends to form more prominent peripancreatic changes than gallstone pancreatitis in relatively severe cases. This is evident on the anterior aspect of left abdomen. Although clinical history and some CT findings usually are a major determinant of the etiology, this pattern of peripancreatic pathology may have an ancillary role in determining the etiologies of acute pancreatitis in the equivocal cases. rat pancreas after induction of acute pancreatitis. Bluth Pancreatic regenerating protein (reg I) stimulates pancreatic regeneration after pancreatectomy and is mitogenic to ductal and beta-cells. This suggests that reg I and its receptor may play a role in recovery after pancreatic injury. The authors hypothesized that reg I and its receptor are induced in acute pancreatitis. Acute pancreatitis was induced in male Wistar rats by retrograde injection of 3% sodium taurocholate into the pancreatic duct. Pancreata and serum were collected 12, 24, and 36 h after injection and from normal controls (4 rats/group). Reg I receptor mRNA, serum reg I protein, and tissue reg I protein levels were determined by Northern analysis, enzyme-linked immunosorbent assay (ELISA), and Western analysis, respectively. Immunohistochemistry was used to localize changes in reg I and its receptor. Serum amylase levels and histology confirmed necrotizing pancreatitis in taurocholate treated rats. There was no statistically significant change in serum reg I concentrations from controls.
However, Western blot demonstrated increased tissue levels of reg I at 24 and 36 h. This increase was localized primarily to the acinar cells and the ductal cells by immunohistochemistry. Northern blot demonstrated a significant increase in reg I receptor mRNA expression with pancreatitis. Immunohistochemistry localized this increase to the ductal cells, islets, and acinar cells. In conclusion, acute pancreatitis results in increased tissue reg I protein levels localized to the acinar and ductal cells, and a parallel threefold induction of reg I receptor in the ductal cells, islets, and acinar cells. These changes suggest that induction of reg I and its receptor may be important for recovery from acute pancreatitis. Anesthesiology and Intensive Care, University Hospital Muenster. Muenster, Germany. Acute pancreatitis has been linked to intestinal barrier dysfunction and systemic inflammatory response with high mortality. Thoracic epidural analgesia improves intestinal perfusion. The authors hypothesized that thoracic epidural analgesia influences microcirculation injury, inflammatory response, and outcome of acute pancreatitis in rats. Control groups underwent a sham procedure or untreated pancreatitis induced by intraductal taurocholate injection. In the treatment groups, epidural analgesia was commenced immediately or after a 7-h delay. Fifteen hours after injury, the ileal mucosal perfusion was assessed by intravital microscopy. Thereby, the intercapillary area between all perfused capillaries and between continuously perfused capillaries only was used to differentially quantify total and continuous capillary mucosal perfusion. Villus blood flow and serum levels of amylase, lactate, and interleukin 6 were determined, and pancreatic injury was scored histologically. Seven-day survival was recorded in an additional 30 rats undergoing untreated pancreatitis or pancreatitis with epidural analgesia. In untreated pancreatitis, decreased total capillary perfusion increased the total intercapillary area by 24%. Furthermore, loss of continuous perfusion increased continuous intercapillary area to 228%. After immediate and delayed epidural analgesia, continuous perfusion was restored (P<0.05). Blood flow decreased 50% in untreated pancreatitis but was preserved by epidural analgesia (P<0.05). Biochemical and histologic signs of pancreatitis were not affected by epidural analgesia. Lactate and interleukin-6 levels increased in untreated pancreatitis, which was prevented in the treatment groups (P<0.05). Epidural analgesia increased 7-day survival from 33% to 73% (P<0.05). In conclusion, thoracic epidural analgesia attenuated systemic response and improved survival in severe acute pancreatitis. These effects might be explained by improved mucosal perfusion. Activation of the NF-kappaB system is a major event in acute and chronic inflammatory processes. NF-kappaB cascades are comprised of IkappaB-kinases, IkappaBs and NF-kappaB dimers. Little is known about the individual roles of these proteins in organspecific inflammation. The aim of the present study was to analyze the consequences of ectopic IkappaB Kinase-2 (IKK2) activation in the pancreas of mice. Transgenic mice were generated using an inducible genetic system (tet-system) to conditionally overexpress a gain of function mutant of IKK2 (tetO-IKK2-EE) in the pancreas. To achieve transgene expression in the pancreas these animals were crossed to CMV-rtTA mice that are shown to express the rtTA protein in the pancreas. In these double-transgenic animals doxycycline treatment induced the expression of IKK2-EE (IKK2CA) in pancreatic acinar cells resulting in a moderate activation of the IkappaB kinase-complex as measured by immune-complex kinase assay, and an up to 200-fold activation of the transgene expression cassette as detected by luciferase assay. IKK2CA expression in the pancreas had a mosaic appearance. Ectopic IKK2CA mostly activated the classical NF-kappaB pathway. The activation level of the NFkappaB cascade induced by IKK2CA was considerably lower compared to that observed after supramaximal caerulein stimulation, but still led to the formation of leukocyte infiltrates first observed after 4 weeks of doxycycline stimulation with a maximum after 8-12 weeks. The infiltrates were mainly composed of B-lymphocytes and macrophages. Increased mRNA levels of TNFalpha and RANTES were detected in pancreatic acinar cells. However, only minor damage of the pancreatic tissue was observed. A combination of supramaximal caerulein stimulation with induction of IKK2CA led to an increased tissue damage compared to either IKK2CA or caerulein alone. In conclusions, these observations suggest that the role of IKK2 activation in pancreatic acini is to induce leucocyte infiltration, however, at a moderate level of activation it is not sufficient to induce pancreatic damage in mice. The IKK2CA-induced infiltrations resemble those observed in autoimmune pancreatitis, indicating a role for IKK2/NFkappaB in this disease. IKK2CA in pancreatic acinar cells increases tissue damage of secretagogue-induced experimental pancreatitis underlining the pro-inflammatory role of the IKK/NF-kappaB pathway in this disease. host response which has been claimed to promote remote organ dysfunction, septic complications, and mortality. Treatment with immunomodulating substances has been subject of few experimental studies with still conflicting results. The authors used the taurocholate-induced model of severe acute pancreatitis (SAP) in rats which were assigned to different treatment regimen: isotonic saline (SAP-S) for nontreated controls, recombinant rat interferon-gamma for immunostimulation (SAP-IFN-gamma), and FK506 for immunosuppression (SAP-FK506). Animals were killed after 3, 6, and 24 hours as well as 3 and 7 days, and parameters of local and systemic severity were assessed. Treatment with IFN-gamma and FK506 attenuated the progression of intrapancreatic necrosis within the first 24 hours after pancreatitis induction along with a substantial reduction of subsequent neutrophil tissue infiltration as shown by decreased myeloperoxidase activity. Enhanced cell death by apoptosis during the postacute course was reduced in FK506-treated animals only. Pancreatic interleukin (IL) 1beta messenger RNA up-regulation occurred early and was slightly suppressed in both treatment groups; tumor necrosis factor alpha (TNFalpha) and IL-2 messenger RNA expression paralleled the onset of apoptosis and was markedly decreased in IFN-gamma-and FK506-treated rats. The two therapeutic regimens had similar effects on intrapancreatic and systemic IL-1beta and TNF-alpha protein release; however, the profiles of both cytokines were differently influenced. Whereas IFN-gamma and FK506 treatment lead to an enhanced intrapancreatic and systemic TNF-alpha protein release during the early course, IL-1beta concentrations were significantly reduced within the late intervals. Seven-day mortality was 44% in saline-, 29% in IFN-gamma-, and 25% in FK506-treated rats (P not significant). In conclusions, severe acute pancreatitis is associated with early alterations of the immune response comprising overt T-cell activation and impaired monocyte/ macrophage function alike. Targeting either immunologic derangement improves local pancreatic damage and systemic severity. However, because mortality was not improved, a therapeutic benefit of immunomodulating substances in clinical SAP remains to be defined.
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In the setting of acute pancreatitis, an admission hematocrit greater than or equal to 44% and/or a failure of hematocrit to drop at 24 hours have been reported as useful markers to predict subsequent necrosis. The authors aimed to validate the use of hemoconcentration as a marker to predict necrosis in adult patients presenting with acute pancreatitis. Patients admitted to the Dartmouth-Hitchcock Medical Center from 1990 to 2003 with a first presentation of acute pancreatitis were identified. Charts were abstracted for baseline demographic and clinical information, including admission and 24-hour hematocrit, and subsequent hospital course. Necrosis was determined based on computed tomography scan. The authors calculated the sensitivity, specificity, positive and negative predictive values (NPV) for different admissions, and 24-hour hematocrit levels in predicting the subsequent development of necrosis. Two hundred thirty patients were identified. Admission hematocrit (greater than or equal to 44%) was a poor predictor of subsequent necrosis with a sensitivity of 52.9%. The absence of hemoconcentration at admission or a drop in 24-hour hematocrit level was reliable in predicting that patients would not develop necrosis (NPV of 94.7% for hematocrit greater than or equal to 44%). Results were similar when the authors compared a range of admission and 24-hour hematocrit values. In conclusions, in a community setting with low rates of necrosis, admission and 24-hour hematocrit levels were not helpful in predicting subsequent necrosis. The absence of admission hemoconcentration had strong NPV for necrosis. However, the actual clinical utility of this test to direct clinical decision making may be limited. Central sensitisation due to visceral pancreatic nociceptive input may play an important role in chronic pancreatitis pain. Using quantitative sensory testing (QST), this study investigates whether thoracoscopic splanchnic denervation (TSD), performed to reduce nociceptive visceral input, affects central sensitisation in chronic pancreatitis patients. The authors studied 19 chronic pancreatitis patients (11 men, 8 women on stable opioid medication) and 18 healthy volunteers as preoperative controls. Preoperatively and 6 weeks after TSD, pain numeric rating scores, opioid medication, and thresholds to electric skin stimulation and pressure pain (measured in dermatomes T10 (pancreas), C5, T4, L1, L4) were documented. Treatment success was defined as cessation of opioids 6 weeks after TSD. Six weeks after TSD, there was a trend towards lower pain scores, only 10 patients were still on opioids (P<0.05 vs. preoperatively) and thresholds overall were significantly higher than preoperatively (pressure pain: +25%, P<0.001; electric: sensation +55%, pain detection +34%, pain tolerance +21%, P<0.05). Gender-specific differences in hypoalgesia patterns were seen.
Preoperatively, TSD treatment successes consumed significantly less opioids than failures, without significant differences in preoperative patterns of neuroplasticity. In conclusions, TSD for chronic pancreatitis pain resulted in fewer patients on opioids and overall increases in pain thresholds. These results suggest that TSD for reducing visceral nociceptive input may be effective in reducing resulting central sensitisation. Although patients benefiting from TSD consume less opioids preoperatively, the authors were unable to clearly link treatment success with specific perioperative patterns of neuroplasticity such as the presence or absence of hyperalgesia.
Cyclooxygenase-2 (Cox-2) mediates various inflammatory responses and is expressed in pancreatic tissue from patients with chronic pancreatitis. To examine the role of Cox-2 in chronic pancreatitis, the authors investigated its participation in regulating functions of pancreatic stellate cells (PSCs), using isolated rat PSCs. Cox-2 was expressed in cultureactivated PSCs but not in freshly isolated quiescent PSCs. TGF-beta1, interleukin (IL)-1beta, and IL-6 enhanced Cox-2 expression in activated PSCs, concomitantly increasing the expression of alpha-smooth muscle actin (alpha-SMA), a parameter of PSC activation. The Cox-2 inhibitor NS-398 blocked cultureactivation of freshly isolated quiescent PSCs. NS-398 also inhibited the enhancement of alpha-SMA expression by TGF-beta1, IL1beta and IL-6 in activated PSCs. These data indicate that Cox-2 is required for the initiation and promotion of PSC activation. The authors further investigated the mechanism by which cytokines enhance Cox-2 expression in PSCs. Adenovirus-mediated expression of dominant-negative Smad2/3 inhibited the increase in expression of Cox-2, alpha-SMA, and collagen-1 mediated by TGF-beta1 in activated PSCs. Moreover, dominant-negative Smad2/3 expression attenuated the expression of Cox-2 and alpha-SMA enhanced by IL-1beta and IL-6. Anti-TGF-beta neutralizing antibody also attenuated the increase in Cox-2 and alpha-SMA expression caused by IL-1beta and IL-6. IL-6 as well as IL-1beta enhanced TGF-beta secretion from PSCs. These data indicate that Smad2/3-dependent pathway plays a central role in Cox-2 induction by TGF-beta1, IL1beta, and IL-6. Furthermore, IL-1beta and IL-6 promote PSC activation by enhancing Cox-2 expression indirectly through Smad2/3-dependent pathway via increasing TGF-beta1 secretion from PSCs. carcinomas, particularly in pancreatic adenocarcinomas. Mutation of the K-ras gene is thought to be an early and important event in pancreatic tumor initiation, but the precise role of the mutant K-Ras proteins in neoplastic progression is still unknown. In the present study, the authors have characterized the influence of oncogenic K-Ras on the phenotype and on the signal transduction of epitheloid PANC-1 pancreatic carcinoma cells by generating PANC-1 cell clones, which stably express EGFP(enhanced green fluorescent protein)-K-Ras (V12). EGFP-KRas (V12)-expressing cells exhibited a more fibroblastoid cellular phenotype with irregular cell shape and disorganized cytokeratin filaments. Moreover, these cells showed a marked enhancement of their migratory and invasive properties. Stable expression of EGFP-K-Ras (V12) down-regulated the activity of Rac1 and RhoA, resulting in reduced subcortical actin filaments and stress fibers, which might contribute to the epithelial dedifferentiation. Characterization of the activity of mitogen-activated protein kinases revealed that EGFP-K-Ras (V12) enhanced the activity of p38, but did not affect the activities of the Raf/MEK/ERK cascade and JNK. While inhibition of either MEK or JNK activity had no effect on EGFP-K-Ras (V12)-induced migration, inhibition of p38 activity markedly reduced EGFP-K-Ras (V12)-induced migration. Collectively, the results suggest that oncogenic K-Ras enhances the malignant phenotype and identify the mitogen-activated protein kinase p38 as a target to inhibit oncogenic K-Ras-induced pancreatic tumor cell migration.
